OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Michal Zuzčák, Ján Trnka
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 24
Michal Zuzčák, Ján Trnka
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 24
Showing 24 citing articles:
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 21
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 21
The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Dinara Baiskhanova, H. Schäfer
Antioxidants (2024) Vol. 13, Iss. 6, pp. 696-696
Open Access | Times Cited: 5
Dinara Baiskhanova, H. Schäfer
Antioxidants (2024) Vol. 13, Iss. 6, pp. 696-696
Open Access | Times Cited: 5
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer
Alice Carrier, Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, et al.
Research Square (Research Square) (2025)
Open Access
Alice Carrier, Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, et al.
Research Square (Research Square) (2025)
Open Access
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 15
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 15
The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application
Shenao Fu, Shaokang Xu, Shubing Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188893-188893
Closed Access | Times Cited: 12
Shenao Fu, Shaokang Xu, Shubing Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188893-188893
Closed Access | Times Cited: 12
Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review
Graziantonio Lauria, Rosita Curcio, Paola Lunetti, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 411-411
Open Access | Times Cited: 10
Graziantonio Lauria, Rosita Curcio, Paola Lunetti, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 411-411
Open Access | Times Cited: 10
Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review
Gloria Perazzoli, Olga María García-Valdeavero, Mercedes Peña, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 872-872
Open Access | Times Cited: 9
Gloria Perazzoli, Olga María García-Valdeavero, Mercedes Peña, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 872-872
Open Access | Times Cited: 9
Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, et al.
Advances in cancer research (2023), pp. 285-341
Closed Access | Times Cited: 7
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, et al.
Advances in cancer research (2023), pp. 285-341
Closed Access | Times Cited: 7
The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma
Yuting Liu, Shing Chun Tang, Chi Han Li, et al.
Cancer Science (2024) Vol. 115, Iss. 10, pp. 3288-3304
Open Access | Times Cited: 2
Yuting Liu, Shing Chun Tang, Chi Han Li, et al.
Cancer Science (2024) Vol. 115, Iss. 10, pp. 3288-3304
Open Access | Times Cited: 2
A mini-review-cancer energy reprogramming on drug resistance and immune response
Chengxiang Liu, Liuxin Yang, Tingting Gao, et al.
Translational Oncology (2024) Vol. 49, pp. 102099-102099
Open Access | Times Cited: 2
Chengxiang Liu, Liuxin Yang, Tingting Gao, et al.
Translational Oncology (2024) Vol. 49, pp. 102099-102099
Open Access | Times Cited: 2
3D culture of pancreatic cancer cellsin vitrorecapitulates an aberrant mitochondrial oxidative phosphorylation genotype observedin vivo
Krzysztof Kuś, J. Mark Treherne, David L. Earnshaw, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Krzysztof Kuś, J. Mark Treherne, David L. Earnshaw, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Pancreatic cancer cells exchange ribosomes through tunneling nanotubes
Stanislava Martínková, Denisa Jansová, Jana Vorel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Stanislava Martínková, Denisa Jansová, Jana Vorel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
Xinlong Zang, Ke Lei, Jia Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155071-155071
Closed Access | Times Cited: 1
Xinlong Zang, Ke Lei, Jia Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155071-155071
Closed Access | Times Cited: 1
Emerging current trends and research focus related to pancreatic cancer metabolism: A bibliometric and visualized analysis
Qian Shen, Chuanlong Zhang, Xiaochen Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Qian Shen, Chuanlong Zhang, Xiaochen Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Chitosan grafted with crown ether with high selectivity and adsorption on lithium-ion
Yuzhe Zhang, Yan Zhang, Yuxi Liu, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2023) Vol. 31, Iss. 6, pp. 538-548
Closed Access | Times Cited: 2
Yuzhe Zhang, Yan Zhang, Yuxi Liu, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2023) Vol. 31, Iss. 6, pp. 538-548
Closed Access | Times Cited: 2
New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents
Irene Conforti, Andrea Benzi, Irene Caffa, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 7, pp. 694-708
Closed Access
Irene Conforti, Andrea Benzi, Irene Caffa, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 7, pp. 694-708
Closed Access
MOLECULAR BASIS OF DRUG RESISTANCE IN PANCREATIC DUCTAL ADENOCARCINOMA, IN VITRO, EX VIVO AND IN VIVO PRECLINICAL MODELS
Yağmur Kaya, Ezel BİLDİK, Hilal Koçdor
Acta Medica Nicomedia (2024) Vol. 7, Iss. 1, pp. 136-147
Open Access
Yağmur Kaya, Ezel BİLDİK, Hilal Koçdor
Acta Medica Nicomedia (2024) Vol. 7, Iss. 1, pp. 136-147
Open Access
Oncometabolites in pancreatic cancer: Strategies and its implications
Arunima Maiti, Susmita Mondal, Shouvik Choudhury, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Arunima Maiti, Susmita Mondal, Shouvik Choudhury, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity
Martine Cordier–Bussat, Alaa Al Assi, Solène Posty, et al.
Research Square (Research Square) (2023)
Open Access
Martine Cordier–Bussat, Alaa Al Assi, Solène Posty, et al.
Research Square (Research Square) (2023)
Open Access
Dissecting the Role of Selenoprotein P and Thioredoxin Reductase in Pancreatic Cancer Metabolism
Alyssa A. Abbas
(2023)
Open Access
Alyssa A. Abbas
(2023)
Open Access
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
Chong Shen, Yuxin Bi, Wang Chai, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access
Chong Shen, Yuxin Bi, Wang Chai, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access
The molecular mechanism underlying KRAS regulation on STK31 expression in Pancreatic ductal adenocarcinoma
Yangchao Chen, Yuting Liu, Shing Chun Tang, et al.
Research Square (Research Square) (2023)
Open Access
Yangchao Chen, Yuting Liu, Shing Chun Tang, et al.
Research Square (Research Square) (2023)
Open Access
Effects of Ketamine, S-Ketamine and MK 801 on Integrin Beta-3-mediated Cell Migration in Pancreatic Carcinoma
Manuela Malsy, Veronika Hofer, Stephan Schmidbauer, et al.
Journal of Cancer Science and Clinical Therapeutics (2022) Vol. 06, Iss. 04
Open Access
Manuela Malsy, Veronika Hofer, Stephan Schmidbauer, et al.
Journal of Cancer Science and Clinical Therapeutics (2022) Vol. 06, Iss. 04
Open Access
